See also this year's filing and all EDGAR filings for this company.
PDF Report 0000920148_2023_Laboratory_Corp_OF_America_Holdings.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000920148, Laboratory Corp OF America Holdings
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 12,067,900,000 |
| 1 | AssetsNonCurrent | 432,700,000 |
| 2 | AssetsCurrent | 4,625,000,000 |
| 3 | PropertyPlantAndEquipment | 2,956,200,000 |
| 4 | remainder_Assets | 73,300,000 |
| 5 | LongTermLiabilities | 6,141,300,000 |
| 6 | LiabilitiesCurrent | 3,814,700,000 |
| 7 | remainder_Liabilities | 83,600,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 10,491,700,000 |
| 10 | GeneralAndAdministrativeExpense | 1,996,600,000 |
| 11 | GoodwillImpairmentLoss | 271,500,000 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 825,400,000 |
| 17 | remainder_Revenues | 14,876,800,000 |
| 18 | remainder_NetIncome | -11,000,000 |
| 19 | remainder_ComprehensiveNetIncome | -302,800,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 20,155,100,000 |
| 1 | Liabilities | 10,039,600,000 |
| 2 | Expenses | 13,585,200,000 |
| 3 | Revenues | 14,876,800,000 |
| 4 | StockholdersEquity | 10,115,500,000 |
| 5 | NetIncome | 1,280,600,000 |
| 6 | ComprehensiveNetIncome | 977,800,000 |
| 7 | BaseVar | 29,485,250,000 |
| 8 | EconomicCapitalRatio | 1.93 |
Edgar->Model Mapping
Feature Distribution
Change over Time
